Concepedia

Christos Fountzilas

CF

Statistics

Publications

42

Citations

4.3K

H-Index

21

Active since

2009

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

University at Buffalo, State University of New York

Christos Fountzilas is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2009–2024

42

Publications

42

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.5K citations · Full text

, , +8

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Margaret A. Tempero, Mokenge P. Malafa, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.2K citations · Full text

Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019

Margaret A. Tempero, Mokenge P. Malafa, E. Gabriela Chiorean et al. · Journal of the National Comprehensive Cancer Network · 2019 · 365 citations

, , +15

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

John H. Strickler, Andrea Cercek, Salvatore Siena et al. · The Lancet Oncology · 2023 · 217 citations

, , +7

Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study

Devalingam Mahalingam, Grey Wilkinson, Kevin H. Eng et al. · Clinical Cancer Research · 2019 · 171 citations · Full text

1–5 of 42